Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma.

MLA

Lam, Maxine SY, et al. “Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma.” Small, vol. 19, no. 52, Dec. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1002/smll.202302280.

APA

Lam, M. S., Aw, J. J., Tan, D., Vijayakumar, R., Lim, H. Y. G., Yada, S., Pang, Q. Y., Barker, N., Tang, C., Ang, B. T., Sobota, R. M., & Pavesi, A. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small, 19(52), 1–16. https://doi.org/10.1002/smll.202302280

Chicago

Lam, Maxine SY, Joey JY Aw, Damien Tan, Ragavi Vijayakumar, Hui Yi Grace Lim, Swathi Yada, Qing You Pang, et al. 2023. “Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma.” Small 19 (52): 1–16. doi:10.1002/smll.202302280.